COLUMN -- Senate prescription bill a free market placeboPosted by Craig Westover | 8:54 AM |
Sep. 15, 2004
Maintaining the ban that prohibits Americans from purchasing less expensive prescription drugs from foreign countries is politically unsustainable. Eliminating the prescription drug reimportation ban is the right thing to do politically and pragmatically. However, it must be done in a way that will not create de facto price controls that curtail research and development of life-saving medicines. . . .
. . . Bottom line, the Senate should reject S.2328 and create a bill in keeping with the spirit and intent of the Gutknecht bill [the Pharmaceutical Market Access Act of 2003]. A simple and effective solution that lifts the reimportation ban and supports minimal federal interference in the market. The free market at its best.
Read the column . . . .
Pioneer Press institutional editorials on prescription drug reimportation --
Push Congress to pass reimportation bill
A good solution in the absence of free market